genprowebdirectory

GEN Edge
News
Insights
- Trends for 2020
A-Lists
Topics
Magazine
- Supplement
Resources
- Posters
- Videos
- Webinars
- eBooks
- Podcasts
- Events
- New Products
- Tutorial
- Best of the Web
- Best Apps
Subscribe

Search

Advertising
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In

GEN – Genetic Engineering and Biotechnology News

Mary Ann Liebert, Inc. Publishers

GEN Edge
- Coronavirus
  
  COVID-19 Puts Spotlight on Artificial Intelligence
  
  Data Management
  
  VAST Ambition When It Comes To Data Storage
  
  Antisense
  
  NeuBase Sets a Course for the Clinic
  
  Bioprocessing
  
  Cytiva Picks Up Where GE Leaves Off after $21B Deal
  
  Coronavirus
  
  Putting COVID-19 on the ‘Map’
News
- Antibodies
  
  Alzheimer’s Oligomeric “Seeds” Recognized by New Antibody
  
  News
  
  Frog Brain Studies May Open Door to Eventually Repairing Birth Defects…
  
  Coronavirus
  
  COVID-19 Triple Play: Merck Acquiring Themis, Partnering with Ridgeback, IAVI
  
  Coronavirus
  
  COVID-19 Accurately Diagnosed by AI Model
  
  Coronavirus
  
  AstraZeneca Wins $1.2B from BARDA to Develop, Manufacture COVID-19 Vaccine
Insights
- All Trends for 2020
  
  Bioprocessing
  
  COVID-19 Will Have Long Lasting Impact on Biopharma Manufacturing
  
  Bioprocessing
  
  Decreasing the Time from Antibody Idea to IND Approval
  
  Bioprocessing
  
  Introducing New Bioprocessing Technologies in the Era of COVID-19
  
  Bioprocessing
  
  Smart AI Use Could Benefit Biopharma
A-Lists
- Coronavirus
  
  Blinking Red: 25 Missed Pandemic Warning Signs
  
  Coronavirus
  
  Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
  
  Coronavirus
  
  Catching Up to Coronavirus: Top 60 Treatments in Development
  
  Drug Discovery
  
  Top 15 Best-Selling Drugs of 2019
  
  Coronavirus
  
  How to Conquer Coronavirus: Top 35 Treatments in Development
Topics
- All Bioprocessing Cancer Drug Discovery OMICs Translational Medicine Genome Editing
  
  Antibodies
  
  Alzheimer’s Oligomeric “Seeds” Recognized by New Antibody
  
  Drug Discovery
  
  CRISPR: A New Break in the GPCR Drug Development Pipeline
  
  Bioprocessing
  
  COVID-19 Will Have Long Lasting Impact on Biopharma Manufacturing
  
  Bioprocessing
  
  Decreasing the Time from Antibody Idea to IND Approval
Magazine
- All Supplement
  
  Coronavirus
  
  Race for a Coronavirus Vaccine
  
  Drug Discovery
  
  Protein Modulation Helps Drug Design Get a Grip
  
  OMICs
  
  Proteomic Mass Spec Assesses Biomolecular Teamwork
  
  Coronavirus
  
  COVID-19 Drives CRISPR Diagnostics
Resources
- All Posters Videos Webinars eBooks Podcasts Events New Products Tutorial Best of the Web Best Apps
  
  Upcoming Webinars
  
  Looking toward the Future of Cell & Gene Therapies
  
  Upcoming Webinars
  
  DNA as Medicine: Encoding Cancer Therapeutic Antibodies
  
  GENcast
  
  Trends in Bioprocess 4.0 and their Impact on Biomanufacturing
  
  Upcoming Webinars
  
  Streamlining High-Throughput Impurity Analysis in Process Development
Subscribe

Home Authors Posts by Josh P. Roberts

Josh P. Roberts

45 POSTS 0 COMMENTS

Josh P. Roberts is a freelance writer who specializes in biomedical science.

Supplement

Fast-Tracking Cell Therapy Manufacturing across Borders

Trends for 2020

Single-Cell Analysis Deepens Antibody Discovery

Bioprocessing

Knocking the Rough Edges Off T-Cell Therapy Manufacturing

Repligen’s XCell™ ATF cell retention devices

Bioprocessing

All Roads Lead to Continuous Processing

Bioprocessing

Single-Use Technology: Enjoy the Upsides, Handle the Downsides

Biomarkers

Signs, Portents, and Immuno-Oncology Biomarkers

Feature Articles

Biomanufacturers Take the Heat off Their Cell Lines

Feature Articles

Supplement: Visions of a Continuous Bioprocess Future

Feature Articles

CAR T Cells Show Solid Progress

Feature Articles

Supplement: CRISPR Enters the Clinic

12 3...5 Page 1 of 5

GEN Edge

COVID-19 Puts Spotlight on Artificial Intelligence

VAST Ambition When It Comes To Data Storage

NeuBase Sets a Course for the Clinic

Cytiva Picks Up Where GE Leaves Off after $21B Deal

Putting COVID-19 on the ‘Map’

All GEN Edge Stories

Recently Featured

Concept of SARS-CoV-2 or 2019-ncov coronavirus

COVID-19 Accurately Diagnosed by AI Model

AstraZeneca Wins $1.2B from BARDA to Develop, Manufacture COVID-19 Vaccine

Gene for “Thinness” Identified that May Help to Resist Weight Gain

Over 200 Genetic Factors Found Linked to Heart Arrhythmias

Cytiva Teams Up with Takara Bio to Work on COVID-19 Vaccine Candidate

Explore

About GEN
Contact GEN
GEN Staff
Editorial Guidelines
Press Releases
Reprints and Permissions
2020 Planning Calendar
Scientific Advisory Board

Advertise

GEN Media Kit
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
List Rental
Advertising Terms and Conditions

Resources

Get the GEN Magazine
Get the GEN Email Newsletter
New Products
Videos
Webinars
Podcasts
Privacy Policy
Clinical OMICs

Home
Terms of Service
Privacy Policy
Cookie Policy
Mary Ann Liebert, Inc.

Scroll Up

Please wait while you are redirected to the right page...

We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our privacy policy.

Edit with Live CSS

Save

Write CSS OR LESS and hit save. CTRL + SPACE for auto-complete.